Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): a systematic review - Lv, X; Dong, Y; Hu, L; Lu, F; Zhou, C; Qin, S (Endocrinol Diabetes Metab, 2020)